Internal Medicine Alert (Vol. 37, No. 18) - September 29, 2015

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: September 2015

Valid through: September 2018

Target Audience

This CME activity is intended for the internist/family physician.


  • SGLT2 Inhibitors: Now The Bad News
  • Is Low Testosterone Therapy Worth the Hype in the Elderly?
  • Migraine and Cognitive Function
  • Pharmacology Update: Alirocumab Injection
  • Cryptogenic Stroke and Atrial Fibrillation
  • Clinical Briefs: Preventing Recurrence of Depression: Cognitive Therapy or Medication?; Predicting Which Patients with Non-alcoholic Fatty Live Disease Will Progress; and Tramadol for Premature Ejaculation


  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available


  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits


This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation


AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins January 15, 2015. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing


Stephen A. Brunton, MD

Adjunct Clinical Professor

University of North Carolina, Chapel Hill; Adjunct Professor of Pharmacy Practice, College of Pharmacy, Roseman University of Health Sciences, Salt Lake City



James Chan, PharmD, PhD

Pharmacy Quality and

Outcomes Manager, Kaiser

Permanente, Oakland, CA


William T. Elliott, MD, FACP

Chair, Formulary Committee,

Northern California Kaiser

Permanente; Assistant Clinical

Professor of Medicine, University of California, San Francisco

Ken Grauer, MD

Professor Emeritus in Family Medicine, College of Medicine,

University of Florida


Seema Gupta, MD, MSPH

Primary Care Physician, Charleston, WV


Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine, UCLA School of Medicine


Louis Kuritzky, MD

Clinical Assistant Professor,

University of Florida, Gainesville


Martin S. Lipsky, MD

Chancellor, South Jordan Campus, Roseman University of Health Sciences, South Jordan, UT

Joseph E. Scherger, MD, MPH

Vice President, Primary Care, Eisenhower Medical Center; Clinical Professor, Keck School of Medicine, University of Southern California


Penny Tenzer, MD

Associate Professor and Vice Chair, Department of Family Medicine and Community Health Chief of Service, Family Medicine, University of Miami Hospital University of Miami Miller School of Medicine


Allan J. Wilke, MD, MA

Professor and Chair Program Director Department of Family Medicine Western Michigan University School of Medicine, Kalamazoo



Gerald Roberts, MD

Senior Attending Physician Long Island Jewish Medical Center NS/LIJ Health Care System New Hyde Park, NY

Financial Disclosure

Financial Disclosure: Internal Medicine Alert’s editor Stephen Brunton, MD, is a retained consultant for Abbott, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, Sanofi, and Teva; he serves on the speakers’ bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing editor Louis Kuritzky is a retained consultant for AbbVie, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chelsea, Daiichi Sankyo, Forest Pharmaceuticals, Janssen, Lilly, Novo Nordisk, Pfizer, and Sanofi.


Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and associate managing editor Jonathan Springston report no financial relationships relevant to this field of study.

Jeff Unger discloses that he receives grant/research support from Novo Nordisk, Eli Lilly, Sanofi Aventis, Boehringer Ingelheim, Janssen, Merck, and GSK; is a retained consultant for Novo Nordisk, Janssen, and Valeritas; is on the speaker’s bureau of Novo Nordisk, Boehringer Ingelheim, Janssen, Valeritas, and Teva; and is a stockholder with Novo Nordisk.

Dr. Dara Jamieson reports she is on the stroke adjudication committee for Bayer and is a consultant for Boehringer-Ingelheim.

Drs. Elliott, Chan, Gupta, and Fink report no relevant financial relationships.


Copyright 2015, AHC Media. All rights reserved.